A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
about
A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@en
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@nl
type
label
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@en
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@nl
prefLabel
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@en
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1476
A retinoic acid receptor β2 ag ...... alcoholic fatty liver disease.
@en
P2093
Jose Jessurun
Lorraine J Gudas
Steven E Trasino
Xiao-Han Tang
P2860
P2888
P304
P356
10.1007/S00109-016-1434-Z
P577
2016-06-06T00:00:00Z